Archive for November 2021

The permit for State Street’s "Fearless Girl" in New York City was scheduled to expire Monday, Nov. 29, but the Boston-based custodial bank is pushing for "landmark" status that would keep the statue there permanently. Read More

Blueprint Medicines Inc. is paying nearly half a million dollars to buy a San Diego-based cancer startup called Lengo Therapeutics. Read More

Adagio Therapeutics Inc. is riding high after the company said its experimental antibody is likely to be just as effective against the omicron variant of the coronavirus as it is against previous variants. The antibody, a drug called ADG20, affords protection for up to one year, according to the firm. Read More

Less than a year after a $7 billion acquisition, investment management company Eaton Vance is planning to move to a smaller headquarters in downtown Boston. It’s a major lease deal at a time when Greater Boston’s office industry is taking steps to recover from the Covid-19 pandemic and subsequent plunge in leasing activity. Read More

One of the state’s largest employers reportedly discussed the idea of buying one of the largest public companies in Massachusetts. Read More

The startup’s platform sets up competitions among sales teams to keep them engaged and entertained. Read More

The Cambridge biotech is retuning its booster development strategy slightly, testing its existing, authorized booster against the new omicron variant of the coronavirus. It is also testing three other experimental boosters. Read More

The medical-device company is establishing its U.S. headquarters in Andover as it starts sales to Massachusetts hospitals of a diagnostic to differentiate between viral and bacterial infections. Read More

Most companies have publicly committed to some version of a hybrid workplace in a post-pandemic world, after nearly two years of remote work that many employees have come to prefer over the office. Read More